These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
391 related items for PubMed ID: 11735742
1. Cardiovascular events and COX-2 inhibitors. Fleming M. JAMA; 2001 Dec 12; 286(22):2808; author reply 2811-2. PubMed ID: 11735742 [No Abstract] [Full Text] [Related]
2. Arthritis. Should you be taking a COX-2 inhibitor? Harv Health Lett; 2001 Nov 12; 27(1):1-3. PubMed ID: 11724695 [No Abstract] [Full Text] [Related]
3. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease. Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J. Pharmacoepidemiol Drug Saf; 2003 Nov 12; 12(1):67-70. PubMed ID: 12616850 [No Abstract] [Full Text] [Related]
4. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs. Atkinson HG. Health News; 2002 Aug 12; 8(8):5. PubMed ID: 12206146 [No Abstract] [Full Text] [Related]
5. The coxibs, selective inhibitors of cyclooxygenase-2. Killen JP. N Engl J Med; 2001 Dec 06; 345(23):1708; author reply 1709. PubMed ID: 11759656 [No Abstract] [Full Text] [Related]
6. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?]. Bannwarth B. Gastroenterol Clin Biol; 2001 Apr 06; 25(4 Suppl):B79-84. PubMed ID: 11449148 [No Abstract] [Full Text] [Related]
7. COX-2 inhibitors: no pain, no heart gain? Harv Heart Lett; 2001 Dec 06; 12(4):2-4. PubMed ID: 11751079 [No Abstract] [Full Text] [Related]
8. [Gastric protective pain therapy. What is the advantage of new COX-2 inhibitors?]. Hinz B, Brune K. MMW Fortschr Med; 2000 Mar 16; 142(11):39-40. PubMed ID: 10786088 [No Abstract] [Full Text] [Related]
9. Selective cyclooxygenase-2 inhibitors: a pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs. Perazella MA, Tray K. Am J Med; 2001 Jul 16; 111(1):64-7. PubMed ID: 11448662 [No Abstract] [Full Text] [Related]
10. COX-2 inhibitors. Magic bullets or merely mortal? Harv Health Lett; 2000 Feb 16; 25(4):4. PubMed ID: 10637015 [No Abstract] [Full Text] [Related]
11. [Specific inhibitors of cyclooxygenase type 2] ]. Tomasová-Studýnková J. Vnitr Lek; 2002 May 16; 48(5):403-8. PubMed ID: 12061207 [Abstract] [Full Text] [Related]
12. The coxibs, selective inhibitors of cyclooxygenase-2. FitzGerald GA, Patrono C. N Engl J Med; 2001 Aug 09; 345(6):433-42. PubMed ID: 11496855 [No Abstract] [Full Text] [Related]
13. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex). Wynn RL. Gen Dent; 2000 Aug 09; 48(1):16-20. PubMed ID: 11199547 [No Abstract] [Full Text] [Related]
14. Efficacy and safety of COX 2 inhibitors. Jones R. BMJ; 2002 Sep 21; 325(7365):607-8. PubMed ID: 12242157 [No Abstract] [Full Text] [Related]
15. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice. Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC. Am J Manag Care; 2002 Oct 21; 8(15 Suppl):S392-400. PubMed ID: 12416789 [Abstract] [Full Text] [Related]
16. COX-2 inhibitors: new drugs for the management of pain and inflammation. Hutchins V, Hutchins B. Dent Today; 2001 Feb 21; 20(2):56-61. PubMed ID: 12524847 [No Abstract] [Full Text] [Related]
17. Coxibs and cardiovascular disease. Fitzgerald GA. N Engl J Med; 2004 Oct 21; 351(17):1709-11. PubMed ID: 15470192 [No Abstract] [Full Text] [Related]